One of the most critical decisions for laboratory directors is whether to invest in an "open" or "closed" immunoassay system. A closed system requires the use of proprietary reagents from the instrument manufacturer, whereas an open system allows the lab to use third-party assays. Both models have profound implications for cost, flexibility, and operational consistency.

Which system model provides better long-term ROI?

Closed systems typically offer better integration and "plug-and-play" simplicity, as the reagents and hardware are optimized for each other. This often results in higher reliability and easier maintenance. However, open systems offer procurement teams more leverage to negotiate reagent prices and the freedom to adopt innovative tests from smaller biotech startups before they are available on major platforms.

How are Open System Immunoassay Analyzers evolving?

The demand for Open System Immunoassay Analyzers is rising among research hospitals that develop their own "laboratory-developed tests" (LDTs). In 2024, manufacturers are responding by creating "hybrid" platforms. These allow for standardized high-volume testing on a closed-loop while providing an open channel for customized or rare-disease assays, balancing efficiency with diagnostic versatility.

• Closed Systems: Higher automation level and lower technical staffing requirements.
• Open Systems: Reduced reagent lock-in and greater flexibility for rare analytes.
• Hybrid Systems: The emerging 2024/2025 standard for academic medical centers.

2025 Strategic Outlook

By 2025, the industry will likely see a move toward "universal consumables." As regulatory bodies push for more standardization, we expect manufacturers to offer more interoperability between hardware and software, potentially easing the transition for labs switching between different diagnostic ecosystems.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com